Evidence map›Paper›PMID 34905122›Full record

ArticleEJNMMI research2021

Detection of the sentinel lymph node with hybrid tracer (ICG-[

Nuria Sánchez-Izquierdo, Sergi Vidal-Sicart, Francisco Campos, Aureli Torné, Martina Aida Angeles, Federico Migliorelli, Meritxell Munmany, Adela Saco, Berta Diaz-Feijoo, Ariel Glickman and 4 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Molecular image-guided surgery in gynaecological cancer: where do we stand?European journal of nuclear medicine and molecular imaging · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 2 countries.

Nuria Sánchez-IzquierdoDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8565-1552
Sergi Vidal-SicartDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6303-3606
Francisco CamposDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9046-8050
Aureli TornéInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4700-9507
Martina Aida AngelesInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4401-3084
Federico MigliorelliDepartment of Gynecology and Obstetrics, Centre Hospitalier Intercommunal des Vallées de l'Ariège, Saint-Jean-de-Verges, France.ORCID http://orcid.org/0000-0002-2185-369X
Meritxell MunmanyInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4435-1542
Adela SacoDepartment of Pathology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9935-9045
Berta Diaz-FeijooInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-6451-1817
Ariel GlickmanInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5233-5545
Jaume OrdiDepartment of Pathology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4820-7954
Andrés PerissinottiDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4190-2425
Marta Del PinoInstitute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2178-2403
Pilar ParedesDepartment of Nuclear Medicine, Hospital Clínic of Barcelona, Villarroel 170, 08036, Barcelona, Spain. pparedes@clinic.cat.ORCID http://orcid.org/0000-0002-8097-9217
Hospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIndocyanine green (ICG) is frequently used for the detection of the sentinel lymph node (SLN) in gynecology, but it carries the loss of the presurgical SLN mapping provided by [

methodsFifty-two patients with intermediate- and high-risk EC underwent SLN biopsy after injection of a hybrid tracer using the TUMIR approach, followed by pelvic and paraaortic lymphadenectomy. SLNs were detected preoperatively by lymphoscintigraphic study and intraoperatively by gamma probe and near-infrared (NIR) optical laparoscopic camera.

resultsPreoperative lymphatic drainage was obtained in 69% and intraoperative detection in 71.4% of patients. A total of 146 SLNs (4.17 SLNs/patient) were biopsied. Pelvic bilateral detection was observed in 57% of the women and paraaortic drainage in 34% of the patients. The radioactive component allowed the detection of SLN in 97.1% of the patients, while the fluorescent component detected 80%. In more than 17% of the patients with intraoperative detection, SLNs were detected only by the radioactive signal. Lymph node metastasis was identified in 14.3% of patients submitted to SLNB. The sensitivity and negative predictive value for metastatic involvement were 100%.

conclusionTUMIR injection of a hybrid tracer in patients with intermediate- and high-risk EC combines the benefits of the radiotracer and the fluorescence methods with a single tracer. The method increases the paraaortic detection rate and allows a potential increase in SLN detection. Notwithstanding, based on our findings, the radioactive component of the hybrid tracer cannot be obviated.

Indexed as

Endometrial cancerHybrid tracer (ICG-[99mTc]Tc-albumin nanocolloid)ICGLymphatic mappingRadiotracerSentinel lymph node

Identifiers

PMID34905122
PMCPMC8671586
OpenAlexW4225855577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.